The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Xanthopoulos Kleanthis G since year 2005.
The trader's CIK number is 1283304.
At the time of this reporting, Xanthopoulos Kleanthis G is the CEO and President of
Anadys Pharmaceuticals Inc
(stock ticker symbol ANDS).
Stock purchases, sales, and option exercises reported by Xanthopoulos Kleanthis G since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2007-08-16
ANDS
Anadys Pharmaceuticals Inc
Purchase
6,500
2.15
13,957
2006-11-14
ANDS
Anadys Pharmaceuticals Inc
Sale
100
5.00
500
2006-05-15
ANDS
Anadys Pharmaceuticals Inc
Sale
5,000
10.49
52,442
2006-04-17
ANDS
Anadys Pharmaceuticals Inc
Sale
5,000
14.82
74,125
2006-03-20
ANDS
Anadys Pharmaceuticals Inc
Sale
5,000
15.36
76,800
2006-03-07
ANDS
Anadys Pharmaceuticals Inc
Option Exercise
30,000
2.95
88,500
2006-03-07
ANDS
Anadys Pharmaceuticals Inc
Sale
30,000
14.67
440,100
2006-03-07
ANDS
Anadys Pharmaceuticals Inc
Option Exercise
30,000
2.95
88,500
2006-03-07
ANDS
Anadys Pharmaceuticals Inc
Sale
30,000
14.67
440,100
2006-02-28
ANDS
Anadys Pharmaceuticals Inc
Sale
6,141
12.99
79,752
2006-02-21
ANDS
Anadys Pharmaceuticals Inc
Sale
5,000
11.81
59,050
2006-01-17
ANDS
Anadys Pharmaceuticals Inc
Sale
5,000
11.03
55,134
2005-12-19
ANDS
Anadys Pharmaceuticals Inc
Sale
5,000
8.15
40,740
2005-11-21
ANDS
Anadys Pharmaceuticals Inc
Sale
5,000
10.58
52,920
2005-10-17
ANDS
Anadys Pharmaceuticals Inc
Sale
5,000
10.90
54,490
2005-09-19
ANDS
Anadys Pharmaceuticals Inc
Sale
5,000
13.38
66,895
2005-08-15
ANDS
Anadys Pharmaceuticals Inc
Sale
5,000
12.84
64,185
2005-07-18
ANDS
Anadys Pharmaceuticals Inc
Sale
5,000
11.24
56,220
2005-06-21
ANDS
Anadys Pharmaceuticals Inc
Sale
5,000
8.62
43,105
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Xanthopoulos Kleanthis G
(CEO and President of Anadys Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
